Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SGLT-2 Inhibitor”

371 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 371 results

Testing effectiveness (Phase 2)Looking for participantsNCT06887062
What this trial is testing

Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Who this might be right for
Large Vessel VasculitisGiant Cell Arteritis (GCA)Takayasu Arteritis
University of Edinburgh 60
Testing effectiveness (Phase 2)UnknownNCT04304560
What this trial is testing

Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial

Who this might be right for
Heart Failure With Reduced Ejection Fraction (HFrEF)Diabete Type 2Cardiomyopathies
Damanhour University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05505994
What this trial is testing

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders+2 more
Daewoong Pharmaceutical Co. LTD. 340
Post-approval studies (Phase 4)Study completedNCT06374043
What this trial is testing

Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus Type 2 With ProteinuriaDiabetes Mellitus+7 more
University Medical Center Groningen 20
Testing effectiveness (Phase 2)Looking for participantsNCT06435858
What this trial is testing

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
Cantonal Hospital Graubuenden 40
Post-approval studies (Phase 4)UnknownNCT05966818
What this trial is testing

Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.

Who this might be right for
Nephrotic Syndrome
Ain Shams University 90
Post-approval studies (Phase 4)Looking for participantsNCT06291155
What this trial is testing

Mechanism of SGLT2 Inhibition in the Kidney

Who this might be right for
Type 2 DiabetesDiabetic Kidney Disease
University of Michigan 20
Testing effectiveness (Phase 2)Looking for participantsNCT07336797
What this trial is testing

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Who this might be right for
Metabolic SyndromeObesity & OverweightHIV (Human Immunodeficiency Virus)
Abdelrahman Mahmoud 66
Very early researchLooking for participantsNCT06229678
What this trial is testing

Ketones, SGLT2, HFrEF

Who this might be right for
Type2diabetesHeart Failure With Reduced Ejection Fraction
The University of Texas Health Science Center at San Antonio 71
Not applicableStudy completedNCT02297620
What this trial is testing

The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Astellas Pharma Inc 8,687
Not applicableStudy completedNCT03200782
What this trial is testing

Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-Study

Who this might be right for
Postprandial HypoglycemiaBariatric SurgeryLate Dumping Syndrome
University Hospital, Basel, Switzerland 12
Not applicableStudy completedNCT02966626
What this trial is testing

A Real World Experience of Dapagliflozin in Type 2 Diabetes

Who this might be right for
Type2 Diabetes
University of Malaya 223
Not applicableUnknownNCT05477017
What this trial is testing

Evaluation of SGLT2-i Effectivness and Safety in Elderly Type 2 Diabetes Patients

Who this might be right for
Type2Diabetes
University of Milan 800
Not applicableUnknownNCT04853615
What this trial is testing

SGLT2 Inhibitors Prophylaxis Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease?

Who this might be right for
SGLT2i Kideny Protection Against Contrast in Diabetic Kidney
Fayoum University 800
Large-scale testing (Phase 3)Study completedNCT03151343
What this trial is testing

SGLT-2 Inhibitor and Myocardial Perfusion, Function and Metabolism in T2 DM Patients at High Cardiovascular Risk

Who this might be right for
Type2 Diabetes Mellitus
Caroline M Kistorp 92
Large-scale testing (Phase 3)Study completedNCT01413204
What this trial is testing

Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 272
Large-scale testing (Phase 3)Looking for participantsNCT06024746
What this trial is testing

Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)

Who this might be right for
Heart Failure
Colorado Prevention Center 1,500
Not applicableEnded earlyNCT05341388
What this trial is testing

The Effect of SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesCognitive Impairment
Goztepe Training and Research Hospital 25
Not applicableStudy completedNCT07379788
What this trial is testing

ARNI Combined With SGLT2 Inhibitors on Functional Mitral Regurgitation Remodeling

Who this might be right for
Heart Failure
Rehab Werida 180
Not applicableLooking for participantsNCT07157475
What this trial is testing

Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors

Who this might be right for
Peripheral Arterial Disease(PAD)
Wroclaw Medical University 300
Load More Results